{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:12:53Z","timestamp":1780463573599,"version":"3.54.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ50135"],"award-info":[{"award-number":["2023JJ50135"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010451","name":"Hunan Province Health Commission","doi-asserted-by":"publisher","award":["20256584"],"award-info":[{"award-number":["20256584"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470590"],"award-info":[{"award-number":["82470590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["2023\\u2212233"],"award-info":[{"award-number":["2023\\u2212233"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.nano.2025.102894","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:16:04Z","timestamp":1767208564000},"page":"102894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges"],"prefix":"10.1016","volume":"71","author":[{"given":"Wenyuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiulin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenran","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102894_bb0005","article-title":"Global, regional and national burden of inflammatory bowel disease in females from 1990 to 2021: an analysis of the global burden of disease study 2021","volume":"6","author":"Peng","year":"2025","journal-title":"Front Global Women\u2019s Health"},{"key":"10.1016\/j.nano.2025.102894_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5217\/ir.2025.00073","article-title":"Evolution of inflammatory bowel disease in Korea: a 60-year perspective on clinical and research development","volume":"23","author":"Yang","year":"2025","journal-title":"Intest Res"},{"key":"10.1016\/j.nano.2025.102894_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clnesp.2025.05.012","article-title":"From traditional to artificial intelligence-driven approaches: revolutionizing personalized and precision nutrition in inflammatory bowel disease","volume":"68","author":"Baldi","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.nano.2025.102894_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","article-title":"Ulcerative colitis","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.nano.2025.102894_bb0025","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3390\/cells14100738","article-title":"Neutrophils at the crossroads of inflammatory bowel disease and atherosclerosis: a state-of-the-art review","volume":"14","author":"Genkel","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.nano.2025.102894_bb0030","article-title":"Potential therapeutic strategies targeting efferocytosis for inflammation resolution and tissue repair in inflammatory bowel disease","volume":"411\u2013412","author":"Li","year":"2025","journal-title":"Cell Immunol"},{"key":"10.1016\/j.nano.2025.102894_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/MOG.0000000000001099","article-title":"Gut-directed therapeutics in inflammatory bowel disease","volume":"41","author":"Kratschmer","year":"2025","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.nano.2025.102894_bb0040","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/pharmaceutics17050547","article-title":"Oral lipid nanoparticles for improving the efficiency of drug delivery systems in ulcerative colitis: recent advances and future prospects","volume":"17","author":"Zhu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102894_bb0045","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2025.102894_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113966","article-title":"Exosome-based mucosal therapeutic and diagnostic system: towards clinical translation","volume":"385","author":"Liu","year":"2025","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0055","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/17435889.2025.2520157","article-title":"Emerging nanocarrier systems for the enhanced delivery of active pharmaceutical ingredients to the intestine","volume":"20","author":"Re","year":"2025","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.nano.2025.102894_bb0060","first-page":"180","article-title":"Updated regulatory considerations for nanomedicines","volume":"5","author":"Subin","year":"2017","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/15548627.2019.1635384","article-title":"New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD","volume":"16","author":"Larabi","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.nano.2025.102894_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149469","article-title":"Genetic and immunological regulation of gut microbiota: the roles of TLRs, CLRs, and key proteins in microbial homeostasis and disease","volume":"955","author":"Ayoub","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.nano.2025.102894_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2017.03.007","article-title":"Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease","volume":"4","author":"Martini","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2025.102894_bb0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1258\/ebm.2011.011358","article-title":"Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence","volume":"237","author":"Zhu","year":"2012","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.nano.2025.102894_bb0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nri3661","article-title":"Cytokines in inflammatory bowel disease","volume":"14","author":"Neurath","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2025.102894_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114634","article-title":"NUDT1 aggravates intestinal epithelial barrier injury through oxidative stress in ulcerative colitis","volume":"155","author":"Jin","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2025.102894_bb0095","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.immuni.2019.03.017","article-title":"Cytokine networks in the pathophysiology of inflammatory bowel disease","volume":"50","author":"Friedrich","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.nano.2025.102894_bb0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.nano.2025.102894_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/dna.2025.0064","article-title":"The role of ETS2 in macrophage inflammation","volume":"44","author":"Stankey","year":"2025","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.nano.2025.102894_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/mi\/8837640","article-title":"Unveiling the role of GRK2: from immune regulation to cancer therapeutics","volume":"2025","author":"Gao","year":"2025","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.nano.2025.102894_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2025.102894_bb0120","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2489067","article-title":"Precision microbiota therapy for IBD: premise and promise","volume":"17","author":"Nagayama","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nano.2025.102894_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.nano.2025.102894_bb0130","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/nu17071174","article-title":"Targeting bile-acid metabolism: nutritional and microbial approaches to alleviate ulcerative colitis","volume":"17","author":"Jiang","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.nano.2025.102894_bb0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s43440-025-00724-7","article-title":"Probiotics: a promising future in the treatment of ulcerative colitis?","volume":"77","author":"C\u00f4co","year":"2025","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.nano.2025.102894_bb0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/antiox14030321","article-title":"Microbial-derived antioxidants in intestinal inflammation: a systematic review of their therapeutic potential","volume":"14","author":"Garc\u00eda Mansilla","year":"2025","journal-title":"Antioxid (Basel Switz)"},{"key":"10.1016\/j.nano.2025.102894_bb0145","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1080\/15548627.2025.2489335","article-title":"Neutrophil-derived serine proteases induce FOXA2-mediated autophagy dysfunction and exacerbate colitis-associated carcinogenesis via protease activated receptor 2","volume":"21","author":"Yuan","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.nano.2025.102894_bb0150","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nano.2025.102894_bb0155","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/gutjnl-2015-311079","article-title":"The safety of vedolizumab for ulcerative colitis and Crohn\u2019s disease","volume":"66","author":"Colombel","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.nano.2025.102894_bb0160","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","article-title":"Ulcerative colitis: epidemiology, diagnosis, and management","volume":"89","author":"Feuerstein","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.nano.2025.102894_bb0165","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.2147\/IJN.S210315","article-title":"Nanoparticle-mediated drug delivery systems for the treatment of IBD: current perspectives","volume":"14","author":"Yang","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125375","article-title":"Nanotechnology-based drug delivery system for targeted therapy of ulcerative colitis from traditional chinese medicine: a review","volume":"673","author":"Gao","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102894_bb0175","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.nano.2025.102894_bb0180","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2147\/IJN.S502546","article-title":"Classification of nanomaterial drug delivery systems for inflammatory bowel disease","volume":"20","author":"Wang","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0185","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: a review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.nano.2025.102894_bb0190","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","article-title":"Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments","volume":"45","author":"Wangchuk","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114101","article-title":"Advances in the treatment of inflammatory bowel disease: focus on polysaccharide nanoparticulate drug delivery systems","volume":"181","author":"Hadji","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0200","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12951-021-01090-1","article-title":"How could nanobiotechnology improve treatment outcomes of anti-TNF-\u03b1 therapy in inflammatory bowel disease? Current knowledge, future directions","volume":"19","author":"Eder","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113828","article-title":"Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD","volume":"175","author":"Hartwig","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0210","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12951-024-02749-1","article-title":"Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease","volume":"22","author":"Cao","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0215","article-title":"Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease","volume":"19","author":"Zheng","year":"2024","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0220","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1039\/D2TB01190E","article-title":"Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease","volume":"10","author":"Li","year":"2022","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2025.102894_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: therapeutic targets for ulcerative colitis","volume":"74","author":"Yao","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/gutjnl-2012-303207","article-title":"Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis","volume":"63","author":"Johansson","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.nano.2025.102894_bb0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0240","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102752","article-title":"The role of the three major intestinal barriers in ulcerative colitis in the elderly","volume":"108","author":"Fu","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0250","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0022-3565(24)29290-9","article-title":"Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease","volume":"299","author":"Lamprecht","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nano.2025.102894_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1425251","article-title":"The emerging role of neutrophil extracellular traps in ulcerative colitis","volume":"15","author":"Long","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102894_bb0260","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jconrel.2020.01.047","article-title":"Macrophage-based nanotherapeutic strategies in ulcerative colitis","volume":"320","author":"Zhang","year":"2020","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0265","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.15710","article-title":"Combination therapy for ulcerative colitis: orally targeted nanoparticles prevent mucosal damage and relieve inflammation","volume":"6","author":"Xiao","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102894_bb0270","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.2147\/JIR.S502388","article-title":"Cerium oxide-loaded exosomes derived from regulatory T cells ameliorate inflammatory bowel disease by scavenging reactive oxygen species and modulating the inflammatory response","volume":"18","author":"Yue","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.nano.2025.102894_bb0275","doi-asserted-by":"crossref","first-page":"277","DOI":"10.15403\/jgld-5172","article-title":"Oxidative stress in gastrointestinal ulcer disease: a gastroenterologist\u2019s view","volume":"32","author":"Popovic","year":"2023","journal-title":"J Gastrointest Liver Dis: JGLD"},{"key":"10.1016\/j.nano.2025.102894_bb0280","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ibd\/izab277","article-title":"Excessive apoptosis in ulcerative colitis: crosstalk between apoptosis, ROS, ER stress, and intestinal homeostasis","volume":"28","author":"Wan","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.nano.2025.102894_bb0285","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12951-025-03322-0","article-title":"Reduction of colitis in mice by chemically programmed supramolecular nanoassemblies of vitamin-lipid conjugates","volume":"23","author":"Xian","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0290","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/acs.molpharmaceut.4c01328","article-title":"Engineered turmeric-derived nanovesicles for ulcerative colitis therapy by attenuating oxidative stress and alleviating inflammation","volume":"22","author":"Lu","year":"2025","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102894_bb0295","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/pharmaceutics17020226","article-title":"pH-dependent drug delivery systems for ulcerative colitis treatment","volume":"17","author":"Gvozdeva","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102894_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12951-023-01889-0","article-title":"Surface-anchored microbial enzyme-responsive solid lipid nanoparticles enabling colonic budesonide release for ulcerative colitis treatment","volume":"21","author":"Zhang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0305","article-title":"Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nano.2025.102894_bb0310","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2490207","article-title":"Gut microbiota and epigenetic inheritance: implications for the development of IBD","volume":"17","author":"Guo","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.nano.2025.102894_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.addr.2014.01.005","article-title":"Human pathological basis of blood vessels and stromal tissue for nanotechnology","volume":"74","author":"Nishihara","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0320","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102894_bb0325","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.7150\/thno.98884","article-title":"Nanotechnology based gas delivery system: a \u201cgreen\u201d strategy for cancer diagnosis and treatment","volume":"14","author":"Chen","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102894_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145104","article-title":"3D-printed laponite\/alginate hydrogel-based suppositories as innovative platforms for AT-MSC secretome delivery in IBD treatment","volume":"318","author":"Munoz-Perez","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"25","key":"10.1016\/j.nano.2025.102894_bb0335","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-728-1","article-title":"Melanin nanoparticles-loaded lactobacillus fermentum exosomes for targeted and visualized treatment of ulcerative colitis","volume":"S2090-1232","author":"Gao","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.nano.2025.102894_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145465","article-title":"Multi-enzyme cascade Fe\/Mo bimetallic nanozyme with mucosal repair function and immunomodulatory capacity for targeted therapy of ulcerative colitis","volume":"319","author":"Xu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102894_bb0345","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.2147\/IJN.S516260","article-title":"How do organelle-targeting nanotherapeutics treat inflammatory diseases? A comprehensive review of the literature","volume":"20","author":"Wang","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0350","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.7150\/thno.73650","article-title":"Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis","volume":"12","author":"Gao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102894_bb0355","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301518","article-title":"Dual-targeted nanoparticle-in-microparticle system for ulcerative colitis therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.nano.2025.102894_bb0360","article-title":"Gingerenone a attenuates ulcerative colitis via targeting IL-17RA to inhibit inflammation and restore intestinal barrier function","volume":"11","author":"Liang","year":"2024","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"10.1016\/j.nano.2025.102894_bb0365","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.3748\/wjg.v23.i23.4200","article-title":"Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: effects in an in vivo model","volume":"23","author":"Dianzani","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2025.102894_bb0370","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1039\/C9CS00309F","article-title":"Nanoparticles\u2019 interactions with vasculature in diseases","volume":"48","author":"Tee","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0375","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","article-title":"The use of alternative strategies for enhanced nanoparticle delivery to solid tumors","volume":"121","author":"Izci","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0380","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.actbio.2020.09.017","article-title":"Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis","volume":"116","author":"Naeem","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102894_bb0385","first-page":"458","article-title":"Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: a brief review","volume":"24","author":"Nidhi","year":"2016","journal-title":"Saudi Pharm J: SPJ: Off Publ Saudi Pharm Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.nano.2025.102894_bb0395","doi-asserted-by":"crossref","first-page":"eado6798","DOI":"10.1126\/sciadv.ado6798","article-title":"Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis","volume":"10","author":"Luo","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.nano.2025.102894_bb0400","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1053\/j.gastro.2021.06.053","article-title":"PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis","volume":"162","author":"Reinisch","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102894_bb0405","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tibtech.2006.02.004","article-title":"Nanoparticles as targeting ligands","volume":"24","author":"Jain","year":"2006","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0410","article-title":"Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102894_bb0415","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ecco-jcc\/jjx115","article-title":"Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis","volume":"12","author":"Zhang","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.nano.2025.102894_bb0420","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ecco-jcc\/jjy181","article-title":"A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages","volume":"13","author":"Deng","year":"2019","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.nano.2025.102894_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0430","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12951-023-02065-0","article-title":"Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion","volume":"21","author":"Zhu","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0435","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2018.08.021","article-title":"TNF\u03b1 gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis","volume":"287","author":"Xiao","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102894_bb0440","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S461977","article-title":"Nanoparticle-based drug delivery systems for inflammatory bowel disease treatment","volume":"18","author":"Gao","year":"2024","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.nano.2025.102894_bb0445","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.117.309813","article-title":"Endothelial functions","volume":"37","author":"Godo","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.nano.2025.102894_bb0450","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.11.003","article-title":"Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model","volume":"138","author":"Laroui","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102894_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116660","article-title":"Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis","volume":"246","author":"Yan","year":"2020","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2025.102894_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.02.010","article-title":"Modality of tumor endothelial VEGFR2 silencing-mediated improvement in intratumoral distribution of lipid nanoparticles","volume":"251","author":"Yamamoto","year":"2017","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0465","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000519363","article-title":"Macrophage-biomimetic nanoparticles ameliorate ulcerative colitis through reducing inflammatory factors expression","volume":"14","author":"Li","year":"2022","journal-title":"J Innate Immun"},{"key":"10.1016\/j.nano.2025.102894_bb0470","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/jfb16010024","article-title":"Biodegradable and stimuli-responsive nanomaterials for targeted drug delivery in autoimmune diseases","volume":"16","author":"Parvin","year":"2025","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.nano.2025.102894_bb0475","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/acsabm.4c01763","article-title":"Multicompartmental hydrogel microspheres with a concentric thin oil layer: protecting and targeting therapeutic agents for inflammatory bowel disease","volume":"8","author":"Jeong","year":"2025","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.nano.2025.102894_bb0480","article-title":"Oral colon-targeted delivery of recombinant human MANF for alleviation of ulcerative colitis","volume":"9","author":"Zhou","year":"2025","journal-title":"Int J Pharm: X"},{"key":"10.1016\/j.nano.2025.102894_bb0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2019.12.024","article-title":"Charge-reversal nanocarriers: an emerging paradigm for smart cancer nanomedicine","volume":"319","author":"Zhang","year":"2020","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0490","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.addr.2012.10.007","article-title":"Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery","volume":"65","author":"Yun","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102894_bb0495","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.2147\/IJN.S471734","article-title":"Research progress of disulfide bond based tumor microenvironment targeted drug delivery system","volume":"19","author":"Ma","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0500","article-title":"ROS-responsive nanoparticles for oral delivery of luteolin and targeted therapy of ulcerative colitis by regulating pathological microenvironment","volume":"14","author":"Tan","year":"2022","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.nano.2025.102894_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102487","article-title":"Thermoresponsive interfaces obtained using poly(N-isopropylacrylamide)-based copolymer for bioseparation and tissue engineering applications","volume":"295","author":"Nagase","year":"2021","journal-title":"Adv Colloid Interf Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0510","doi-asserted-by":"crossref","first-page":"26298","DOI":"10.1021\/acsami.3c02128","article-title":"Colon-targeting angelica sinensis polysaccharide nanoparticles with dual responsiveness for alleviation of ulcerative colitis","volume":"15","author":"Xu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102894_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123339","article-title":"Orally-deliverable liposome-microgel complexes dynamically remodel intestinal environment to enhance probiotic ulcerative colitis therapy via TLR4 inhibition and tryptophan metabolic crosstalk","volume":"321","author":"Fu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102894_bb0520","doi-asserted-by":"crossref","first-page":"22901","DOI":"10.1021\/acsnano.3c08030","article-title":"MicroRNA-200 loaded lipid nanoparticles promote intestinal epithelium regeneration in canonical MicroRNA-deficient mice","volume":"17","author":"Wei","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102894_bb0525","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.1021\/acsnano.3c11257","article-title":"Inhibiting the cGAS-STING pathway in ulcerative colitis with programmable micelles","volume":"18","author":"Uthaman","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102894_bb0530","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jconrel.2025.02.043","article-title":"Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-\u03b1 antibody therapeutic in ulcerative colitis treatment","volume":"380","author":"Zhang","year":"2025","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2025.214232","article-title":"Digital light processing of photo-crosslinkable gelatin to create biomimetic 3D constructs serving small intestinal tissue regeneration","volume":"171","author":"Maes","year":"2025","journal-title":"Biomater Adv"},{"key":"10.1016\/j.nano.2025.102894_bb0540","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1021\/acs.biomac.7b00728","article-title":"Folate-targeted dendrimers selectively accumulate at sites of inflammation in mouse models of ulcerative colitis and atherosclerosis","volume":"18","author":"Poh","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2025.102894_bb0545","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-024-02701-3","article-title":"Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges","volume":"22","author":"Narayana","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0550","doi-asserted-by":"crossref","first-page":"66486","DOI":"10.1007\/s11356-023-27167-y","article-title":"New insights into the role of metal(loid)s in the development of ulcerative colitis: a systematic review","volume":"30","author":"Bagherzadeh","year":"2023","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.nano.2025.102894_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142699","article-title":"Polydopamine-mediated biointerfacial nanozyme as probiotic protective coating for IBD therapy","volume":"308","author":"Zhang","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102894_bb0560","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.apsb.2021.04.001","article-title":"Oral delivery of proteins and peptides: challenges, status quo and future perspectives","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.nano.2025.102894_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123231","article-title":"Nanozyme-functionalized microalgal biohybrid microrobots in inflammatory bowel disease treatment","volume":"319","author":"Yang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102894_bb0570","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/2211738511666221026163303","article-title":"Solid lipid nanoparticles (SLNs): advancements in modification strategies toward drug delivery vehicle","volume":"11","author":"Al-Sayadi","year":"2023","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0575","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1080\/10717544.2022.2058646","article-title":"Application of chitosan\/alginate nanoparticle in oral drug delivery systems: prospects and challenges","volume":"29","author":"Li","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102894_bb0580","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13346-018-0512-x","article-title":"Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects","volume":"9","author":"Sohail","year":"2019","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.nano.2025.102894_bb0585","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7150\/thno.87739","article-title":"Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles","volume":"14","author":"Zhuo","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102894_bb0590","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/nano10050847","article-title":"Polymeric nanocapsules as nanotechnological alternative for drug delivery system: current status, challenges and opportunities","volume":"10","author":"Deng","year":"2020","journal-title":"Nanomater (Basel Switz)"},{"key":"10.1016\/j.nano.2025.102894_bb0595","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/138920012800166490","article-title":"Pharmacokinetics and disposition of nanomedicine using biodegradable PEG\/PCL polymers as drug carriers","volume":"13","author":"Wang","year":"2012","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.nano.2025.102894_bb0600","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.05.028","article-title":"PEG-PCL-based nanomedicines: a biodegradable drug delivery system and its application","volume":"260","author":"Grossen","year":"2017","journal-title":"J Control Release: Off J Control Release Soc"},{"key":"10.1016\/j.nano.2025.102894_bb0605","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2219427","article-title":"Responsive nanosystems for targeted therapy of ulcerative colitis: current practices and future perspectives","volume":"30","author":"Chen","year":"2023","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102894_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141567","article-title":"Preparation of pH-enzyme dual-responsive gel microspheres and their treatment of ulcerative colitis","volume":"306","author":"Geng","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102894_bb0615","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1039\/D3TB00027C","article-title":"Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents","volume":"11","author":"Sun","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2025.102894_bb0620","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41392-023-01654-7","article-title":"Multifunctional mesoporous silica nanoparticles for biomedical applications","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2025.102894_bb0625","first-page":"930","volume":"6","author":"Ma","year":"2016","journal-title":"Dendritic polymers for theranostics Theranostics"},{"key":"10.1016\/j.nano.2025.102894_bb0630","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/11205870-000000000-00000","article-title":"MMX\u00ae mesalazine: a review of its use in the management of mild to moderate ulcerative colitis","volume":"71","author":"Yang","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2025.102894_bb0635","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s40265-015-0396-8","article-title":"Budesonide MMX(\u00ae): a review of its use in patients with mild to moderate ulcerative colitis","volume":"75","author":"Hoy","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2025.102894_bb0640","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s40265-014-0253-1","article-title":"Vedolizumab: first global approval","volume":"74","author":"Poole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2025.102894_bb0645","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.biomaterials.2010.09.062","article-title":"Functional TNF\u03b1 gene silencing mediated by polyethyleneimine\/TNF\u03b1 siRNA nanocomplexes in inflamed colon","volume":"32","author":"Laroui","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102894_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119351","article-title":"Advances in the colon-targeted chitosan based multiunit drug delivery systems for the treatment of inflammatory bowel disease","volume":"288","author":"Kulkarni","year":"2022","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2025.102894_bb0655","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12951-023-02045-4","article-title":"Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair","volume":"21","author":"Lei","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0660","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","article-title":"Ulcerative colitis: molecular insights and intervention therapy","volume":"5","author":"Liang","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.nano.2025.102894_bb0665","first-page":"1171","article-title":"Curcumin therapy for ulcerative colitis remission: systematic review and meta-analysis. Expert rev","volume":"14","author":"Goulart","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2025.102894_bb0670","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12951-025-03376-0","article-title":"Lactobacillus acidophilus extracellular vesicles-coated UiO-66-NH2@siRNA nanoparticles for ulcerative colitis targeted gene therapy and gut microbiota modulation","volume":"23","author":"Cui","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114619","article-title":"Role of pyroptosis in inflammatory bowel disease","volume":"155","author":"Xiao","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2025.102894_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118012","article-title":"Baicalin n-butyl ester alleviates inflammatory bowel disease and inhibits pyroptosis through the ROS\/ERK\/P-ERK\/NLRP3 pathway in vivo and in vitro","volume":"186","author":"Guo","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2025.102894_bb0685","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00418-023-02182-9","article-title":"nanoGold and \u03bcGold inhibit autoimmune inflammation: a review","volume":"159","author":"Danscher","year":"2023","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.nano.2025.102894_bb0690","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1186\/s12951-024-02964-w","article-title":"Physical, biochemical, and biological characterization of olive-derived lipid nanovesicles for drug delivery applications","volume":"22","author":"Zhao","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156633","article-title":"Quercetin protected the gut barrier in ulcerative colitis by activating aryl hydrocarbon receptor","volume":"140","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2025.102894_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70113","article-title":"Thymoquinone ameliorates gut epithelial injury by suppressing the JNK signaling pathway based on its anti-oxidant property","volume":"13","author":"Jia","year":"2025","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.nano.2025.102894_bb0705","article-title":"TCP80-1, a new Levan-neoseries fructan from tupistra chinensis baker rhizomes alleviates ulcerative colitis induced by dextran sulfate sodium in drosophila melanogaster model","volume":"203","author":"Wang","year":"2025","journal-title":"Food Res Int (Ott Ont,)"},{"key":"10.1016\/j.nano.2025.102894_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114606","article-title":"HucMSC-ex alleviates inflammatory bowel disease by regulating O-GlcNAcylation modification of RACK1 in intestinal epithelial cells","volume":"251","author":"Liu","year":"2025","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.nano.2025.102894_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114501","article-title":"IsoalloLCA-intervened regulatory T cell exosomes alleviate inflammatory bowel disease by inhibiting NF-\u03baB-associated inflammation in intestinal epithelial cells","volume":"154","author":"Yue","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2025.102894_bb0720","article-title":"CO-releasing polyoxometalates nanozyme with gut mucosal immunity and microbiota homeostasis remodeling effects for restoring intestinal barrier integrity","volume":"12","author":"Lu","year":"2025","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"10.1016\/j.nano.2025.102894_bb0725","doi-asserted-by":"crossref","DOI":"10.1042\/EBC20253003","article-title":"Engineered bacteria and bacterial derivatives as advanced therapeutics for inflammatory bowel disease","volume":"69","author":"Wu","year":"2025","journal-title":"Essays Biochem"},{"key":"10.1016\/j.nano.2025.102894_bb0730","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cmi.2022.08.027","article-title":"Microbiome-phage interactions in inflammatory bowel disease","volume":"29","author":"Federici","year":"2023","journal-title":"Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.nano.2025.102894_bb0735","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12951-023-01976-2","article-title":"\u201cDual sensitive supramolecular curcumin nanoparticles\u201d in \u201cadvanced yeast particles\u201d mediate macrophage reprogramming, ROS scavenging and inflammation resolution for ulcerative colitis treatment","volume":"21","author":"Han","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0740","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12951-025-03322-0","article-title":"Reduction of colitis in mice by chemically programmed supramolecular nanoassemblies of vitamin\u2013lipid conjugates","volume":"23","author":"Xian","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125428","article-title":"Dextran sulfate-coated curcumin nanocrystals for the treatment of DSS-induced ulcerative colitis in mice","volume":"674","author":"Li","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102894_bb0750","article-title":"Chiral zinc sulfide nanoparticles scavenging reactive oxygen species for remodeling intestinal homeostasis","volume":"64","author":"Luo","year":"2025","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.nano.2025.102894_bb0755","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1039\/D2BM01256A","article-title":"Hyaluronic acid\/serotonin-decorated cerium dioxide nanomedicine for targeted treatment of ulcerative colitis","volume":"11","author":"Gao","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0760","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2217\/nnm.15.188","article-title":"The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery","volume":"11","author":"Corbo","year":"2016","journal-title":"Nanomed (Lond Engl)"},{"key":"10.1016\/j.nano.2025.102894_bb0765","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/ijms22010385","article-title":"Safe nanoparticles: are we there yet?","volume":"22","author":"Najahi-Missaoui","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0770","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0775","article-title":"Continued efforts on nanomaterial-environmental health and safety is critical to maintain sustainable growth of nanoindustry","volume":"16","author":"Liu","year":"2020","journal-title":"Small Weinh Bergstr Ger"},{"key":"10.1016\/j.nano.2025.102894_bb0780","first-page":"937","article-title":"Droplet-based microfluidics: applications in pharmaceuticals","volume":"16","author":"Trinh","year":"2023","journal-title":"Pharm (Basel Switz)"},{"key":"10.1016\/j.nano.2025.102894_bb0785","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2019.06.027","article-title":"Achieving continuous manufacturing in lyophilization: technologies and approaches","volume":"142","author":"Pisano","year":"2019","journal-title":"Eur J Pharm Biopharm: Off J Arbeitsgemeinschaft Fur Pharm Verfahrenstechnik eV"},{"key":"10.1016\/j.nano.2025.102894_bb0790","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.nano.2025.102894_bb0795","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12951-023-02065-0","article-title":"Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion","volume":"21","author":"Zhu","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102894_bb0800","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025058","article-title":"Tumor necrosis factor-\u03b1 and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitis","volume":"6","author":"Dharmani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2025.102894_bb0805","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4196\/kjpp.2014.18.4.279","article-title":"A review on chemical-induced inflammatory bowel disease models in rodents","volume":"18","author":"Randhawa","year":"2014","journal-title":"Korean J Physiol Pharmacol: Off J Korean Physiol Soc Korean Soc Pharmacol"},{"key":"10.1016\/j.nano.2025.102894_bb0810","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory bowel disease: a review of pre-clinical murine models of human disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102894_bb0815","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","article-title":"Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice","volume":"66","author":"Sellon","year":"1998","journal-title":"Infect Immun"},{"issue":"170","key":"10.1016\/j.nano.2025.102894_bb0820","first-page":"3939","article-title":"Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells","volume":"2003","author":"Mottet","year":"1950","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.nano.2025.102894_bb0825","article-title":"The role of organoids as a novel platform for modeling of inflammatory bowel disease","volume":"9","author":"O\u2019Connell","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.nano.2025.102894_bb0830","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41598-018-21201-7","article-title":"Development of a primary human small intestine-on-a-chip using biopsy-derived organoids","volume":"8","author":"Kasendra","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102894_bb0835","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cgh.2024.06.036","article-title":"The future of clinical trials in inflammatory bowel disease","volume":"23","author":"Ma","year":"2025","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.nano.2025.102894_bb0840","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/j.gastro.2023.02.031","article-title":"Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis","volume":"164","author":"Iacucci","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nano.2025.102894_bb0845","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2025.102894_bb0850","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2025.102894_bb0855","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102894_bb0860","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202513718","article-title":"A DNA nanopatch-bacteriophage system targeting streptococcus gallolyticus for inflammatory bowel disease treatment and colorectal cancer prevention","volume":"37","author":"Zhao","year":"2025","journal-title":"Adv Mater (Deerf Beach Fla,)"},{"key":"10.1016\/j.nano.2025.102894_bb0865","first-page":"10","article-title":"Potential applications of engineered bacteria in disease diagnosis and treatment","volume":"4","author":"Luo","year":"2025","journal-title":"Microbiome Res Rep"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:08:40Z","timestamp":1768979320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":173,"alternative-id":["S1549963425000954"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102894","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102894"}}